1. Home
  2. TRVI vs LINC Comparison

TRVI vs LINC Comparison

Compare TRVI & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • LINC
  • Stock Information
  • Founded
  • TRVI 2011
  • LINC 1946
  • Country
  • TRVI United States
  • LINC United States
  • Employees
  • TRVI N/A
  • LINC N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • LINC Other Consumer Services
  • Sector
  • TRVI Health Care
  • LINC Real Estate
  • Exchange
  • TRVI Nasdaq
  • LINC Nasdaq
  • Market Cap
  • TRVI 629.8M
  • LINC 729.2M
  • IPO Year
  • TRVI 2019
  • LINC 2005
  • Fundamental
  • Price
  • TRVI $5.96
  • LINC $22.48
  • Analyst Decision
  • TRVI Strong Buy
  • LINC Strong Buy
  • Analyst Count
  • TRVI 8
  • LINC 4
  • Target Price
  • TRVI $19.31
  • LINC $24.00
  • AVG Volume (30 Days)
  • TRVI 2.6M
  • LINC 282.8K
  • Earning Date
  • TRVI 08-07-2025
  • LINC 08-07-2025
  • Dividend Yield
  • TRVI N/A
  • LINC N/A
  • EPS Growth
  • TRVI N/A
  • LINC N/A
  • EPS
  • TRVI N/A
  • LINC 0.39
  • Revenue
  • TRVI N/A
  • LINC $454,204,000.00
  • Revenue This Year
  • TRVI N/A
  • LINC $13.40
  • Revenue Next Year
  • TRVI N/A
  • LINC $8.42
  • P/E Ratio
  • TRVI N/A
  • LINC $57.98
  • Revenue Growth
  • TRVI N/A
  • LINC 15.24
  • 52 Week Low
  • TRVI $2.36
  • LINC $10.31
  • 52 Week High
  • TRVI $7.48
  • LINC $24.20
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 43.31
  • LINC 56.61
  • Support Level
  • TRVI $6.05
  • LINC $22.16
  • Resistance Level
  • TRVI $6.49
  • LINC $22.90
  • Average True Range (ATR)
  • TRVI 0.53
  • LINC 0.84
  • MACD
  • TRVI -0.05
  • LINC -0.18
  • Stochastic Oscillator
  • TRVI 27.62
  • LINC 54.18

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

Share on Social Networks: